1-2 of 2
Yi Hong, PhD
Close
Sort by
Journal Articles

Developing a Novel Anti-CD19/CD20 Bi-Specific Chimeric Antigen Receptor T (CAR-T) Cell Therapy for Relapsed/Refractory (r/r) B-Cell NHL

Lili Zhou, MD, Jiaqi Huang, PhD, Shigui Zhu, PhD, Xin Yao, PhD, Shiguang Ye, Judy Zhu, MD, Chengxiao Zheng, MD, Shiyi Chen, Yanfeng Li, MS, Liping Lan, MS, Shicheng Chen, Lin Guo, PhD, Qingsong Zhang, MS, Jiangqin Zheng, Rirfei Wang, MS, Yi Hong, PhD, Jiaqiang Ren, MD PhD, Li Zhang, MD, Wenjun Zhang, MD, Xiaochen Tang, Junbang Wang, Jie Liu, Michael Humphries, MD, Ping Li, MD, Yihong Yao, PhD, Aibin Liang, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 8.
https://doi.org/10.1182/blood-2020-137826
Published: 2020
Journal Articles

Early Clinical Results of a Novel Anti-CD20 Chimeric Antigen Receptor (CAR)-T Cell Therapy for B-Cell NHL Patients Who Are Relapsed/Resistant Following CD19 CAR-T Therapy

Shiguang Ye, Jiaqi Huang, PhD, Shigui Zhu, PhD, Xin Yao, PhD, Lili Zhou, MD, Judy Zhu, MD, Chengxiao Zheng, MD, Shiyi Chen, Liping Lan, MS, Shicheng Chen, Yutian Wei, MS, Wangqin Shu, MS, Chen Ye, Dan Zhang, Rirfei Wang, MS, Yi Hong, PhD, Jiaqiang Ren, MD PhD, Li Zhang, MD, Wenjun Zhang, MD, Xiaochen Tang, Junbang Wang, Jie Liu, Michael Humphries, MD, Ping Li, MD, Yihong Yao, PhD, Aibin Liang, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 8–9.
https://doi.org/10.1182/blood-2020-138538
Published: 2020